8 February 2019
The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2019 on Tuesday 30th April in Oxford. It's our annual meeting packed with short talks and posters on cancer metabolism, neuroscience, diabetes, mitochondrial disorders and general mitochondrial biology.
30 January 2019
The latest findings from the international INTERGROWTH-21st Project, that has monitored healthy, urban children from educated families across four continents from early pregnancy to 2 years of age, show that human neurodevelopment is not influenced by the colour of an individual’s skin.
8 January 2019
A new three-year graduate research scholarship based in the Nuffield Department of Women’s and Reproductive Health has been launched, thanks to a generous donation by the Bahceci Health Group.
Women in China have greater awareness, treatment, and control of high blood pressure than men, new research finds
6 December 2018
Women in China have greater awareness, treatment, and control of hypertension than their male counterparts, new research from The George Institute for Global Health at the University of Oxford has found.
30 November 2018
A study published in The Lancet Infectious Diseases shows the extraordinary global genetic diversity of HIV and highlights just how big the challenge is to develop a vaccine to combat the global spread of HIV.
19 November 2018
Principal Investigator Dr Suzannah Williams and DPhil student Charlotte Walker from the Nuffield Department of Women's & Reproduction Health discuss what is considered a safe childbearing age, in the academic journal The Conversation.
Smoking, diabetes and high blood pressure increase women’s risk of experiencing a heart attack more than men’s, new research shows
8 November 2018
Smoking, diabetes and high blood pressure increase the risk of a heart attack more in women than in men, new research from The George Institute for Global Health at the University of Oxford has found.
18 October 2018
A smartphone application for women with gestational diabetes, developed with support from NIHR Oxford Biomedical Research Centre, has been launched commercially.
11 October 2018
A new test that predicts with almost 100 per cent accuracy that a pregnant woman will not develop pre-eclampsia within the following seven days has been given the green light to be used as standard clinical practice in one of the UK’s biggest acute hospital trusts.
3 October 2018
The Family Larsson-Rosenquist Foundation (FLRF) has awarded £2.9 million to the Nuffield Department of Women’s & Reproductive Health at the University of Oxford to establish a research centre focused on studying the endocrinology of human lactation.
24 September 2018
We are delighted to let you know that the Medical Sciences Division Board has conferred the title of Associate Professor on Katy Vincent, Senior Pain Fellow, and Roberto Tozzi, Honorary Senior Clinical Lecturer.
9 August 2018
Everyone is invited to attend the 2nd UK Fertility Preservation Conference on 14 September 2018 at St. Anne’s College at the University of Oxford. This meeting follows on from the 1st highly successful meeting in Edinburgh in 2017. Oxford is home to The Future Fertility Trust which is the main Fertility Preservation Centre in England. They provide a comprehensive tissue cryopreservation service for girls, boys and young adults alongside a dynamic research programme.
6 August 2018
Dr Lucy Mackillop, Dr Jane Hirst and their team from the Nuffield Department of Women's & Reproductive Health have won an award at the University’s first Vice-Chancellor’s Innovation Awards. Their GDm-healthTM: real-time management of gestational diabetes project was awarded ‘highly commended’ in the ‘Team Work’ category. The GDm-Health app allows pregnant women to track their blood glucose levels and stay in touch with their healthcare team.
23 July 2018
A global review involving almost 20 million people has shown that having diabetes significantly raises the risk of developing cancer, and for women the risk is even higher.
12 July 2018
Pregnant women are being invited by the University of Oxford and the NHS to take part in the world’s first clinical trial to prevent type 1 diabetes in babies and infants.Researchers want to find out if giving small amounts of oral insulin to babies on the National Institute for Health Research-supported trial can prevent type 1 diabetes, thus allowing mothers to protect their children from injecting insulin.
9 July 2018
Investigation of endometriosis-associated pain and interstitial cystitis/bladder pain syndrome by public-private partnership. Chronic pelvic pain is a condition with high unmet medical need and has a significant impact on quality of life, work efficiency & healthcare utilization. The disorder is frequently associated with endometriosis and bladder pain syndrome/interstitial cystitis – debilitating diseases affecting millions of women worldwide. An important new research programme focused on these diseases has recently been launched. It will be undertaken by a large international consortium including leading academic centres, small and medium-sized enterprises (SMEs), pain societies, patient organizations and pharmaceutical industry partners.
17 May 2018
Dr Jenny Tran (from The George Institute, Nuffield Department of Women's & Reproductive Health) is already a medical doctor, Rhodes scholar, and one of Forbes’ ‘30 under 30’, and she can now add Asian Women of Achievement award-winner to her list of accolades.
27 March 2018
Professor Terry Dwyer is stepping down from his role as Executive Director of The George Institute for Global Health at the University of Oxford to focus on his research into children’s cancer and childhood risk factors for heart disease and cancer in adults.
12 March 2018
Women with bigger waists relative to their hips face a proportionately greater risk of experiencing a heart attack than men who have a similar ‘apple shape’, new research from The George Institute for Global Health, (Nuffield Department of Women's & Reproductive Health).
12 March 2018
Professor Ahmed's lab is leading groundbreaking research to find ways of making paclitaxel chemotherapy more effective. Whilst many patients with ovarian cancer respond well to paclitaxel, about 60% do not. Overcoming such resistance to chemotherapy is a major challenge.